Company Filing History:
2 out of 116 
2 out of 2 
2 out of 25 Years Active: 1997-1998
Title: Francine Durocher: Innovator in Human Genetics
Introduction
Francine Durocher is a prominent inventor based in Ste-Foy, Canada. She has made significant contributions to the field of human genetics, particularly in the area of cancer susceptibility. With a total of 2 patents, her work has had a profound impact on cancer diagnosis and therapy.
Latest Patents
One of her latest patents focuses on the linked breast and ovarian cancer susceptibility gene, specifically the BRCA1 gene. This invention relates to methods and materials used to isolate and detect the BRCA1 gene, which is known to predispose individuals to breast and ovarian cancer. The patent details the significance of germline mutations in the BRCA1 gene for diagnosing predisposition to these cancers. Additionally, it addresses somatic mutations in the BRCA1 gene and their implications for the diagnosis and prognosis of human breast and ovarian cancer. The invention also explores therapeutic approaches for cancers associated with BRCA1 mutations, including gene therapy and drug screening.
Career Highlights
Throughout her career, Francine Durocher has worked with notable organizations such as Myriad Genetics, Inc. and Centre De Recherche Du Chul. Her expertise in genetics has positioned her as a key figure in cancer research and innovation.
Collaborations
She has collaborated with esteemed colleagues, including Donna M Shattuck-Eidens and Jacques Simard, further enhancing her contributions to the field.
Conclusion
Francine Durocher's innovative work in human genetics, particularly regarding the BRCA1 gene, has paved the way for advancements in cancer diagnosis and treatment. Her contributions continue to influence the medical community and improve patient outcomes.